Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Intangibles (Net)

Intangibles (Net) at other companies

Rogers Corporation logo
Rogers CorporationROG
$95.8M-12.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$467.16M-10.6%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$174M-1.4%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$15M-6.3%
Alumis Inc. logo
Alumis Inc.ALMS
$50.96M—
LQD
Liquidia CorporationLQDA
$2.89M-7.1%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's intangibles (net)?
Aurinia Pharmaceuticals (AUPH) reported intangibles (net) of $3.59M in Q1 2026.
How has Aurinia Pharmaceuticals's intangibles (net) changed year-over-year?
Aurinia Pharmaceuticals's intangibles (net) decreased by 13.7% year-over-year, from $4.16M to $3.59M.
What is the long-term trend for Aurinia Pharmaceuticals's intangibles (net)?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's intangibles (net) has grown at a -16.6% compound annual growth rate (CAGR), from $9.33M to $3.76M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.